RecruitingNCT05190848

Correlation of Microbiome and Metabonomics With IgA Nephropathy


Sponsor

Guangdong Provincial People's Hospital

Enrollment

600 participants

Start Date

May 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

IgAN is the most prevalent primary glomerulonephritis in China, is characterized by the deposition of IgA1 (particularly, galactose-deficient IgA1) in the glomerular mesangium. Galactosedeficient IgA1, supposed to be produced by Peyer patches in the mucosa-associated lymphoid tissue (MALT), is triggered by exposure to commensal or pathogenic bacteria, involved in the initial step in the pathogenesis of IgAN. Similar to intestinal flora, a disruption in oral flora is closely associated with the occurrence of many malignant tumors and autoimmune diseases. The relationship between oral and throat microflora and the occurrence of IgAN is unclear at present. The aim of the present study was to develop a preliminary model based on mucosa -specific microbes and clinical indicators to facilitate the early diagnosis of IgAN and obtain insights into its treatment.


Eligibility

Min Age: 16 YearsMax Age: 65 Years

Inclusion Criteria1

  • (1) Pathological changes of IgAN were confirmed by renal biopsy (2) Age ≥16 years (3) IgA deposition caused by secondary factors such as non-purpura glomerulonephritis, liver cirrhosis, SLE, HIV infection and hepatitis B virus associated nephritis (4) No antibiotics and/or functional foods (probiotics and/or prebiotics) for at least one month prior to sampling (5) No hormone or immunosuppressant treatment in the six months prior to sampling (6) No significant changes in diet or medication for at least one month (7) No other immune or autoimmune diseases, such as systemic lupus erythematosus (8) Signed informed consent

Exclusion Criteria6

  • Type I or type II diabetes
  • Pregnancy and menstrual period
  • Mental illness and inability to assess follow-up
  • Medically diagnosed intestinal diseases such as irritable bowel syndrome and inflammatory bowel disease
  • Viral hepatitis or other infectious diseases
  • One month before specimen collection, use laxatives including but not limited to polyethylene glycol electrolyte dispersant, enema and other laxatives

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(5)

Sun Yat-sen Memorial Hospital Sun Yat-sen university

Guangzhou, Guangdong, China

The Third Affiliated Hospital of Southern Medical University

Guangzhou, Guangdong, China

The Third Affiliated Hospital of Sun Yat-sen University

Guangzhou, Guangdong, China

Guangdong Provincial People's Hospital

Guanzhou, Guangdong, China

The First Affiliated Hospital of Sun Yat-sen University

Guanzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05190848


Related Trials